News archive 2010

30 July 2010
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary

13 July 2010
SYMPHOGEN Issued United States Patent Covering Symplex Technology for Antibody Discovery

12 July 2010
ABLYNX – Novartis Obtains Licenses to Develop and Commercialize Two Novel NANOBODIES®

21 June 2010
MTM Laboratories - p16 Immuno-cytochemistry shows superior clinical performance to HPV testing for the identification of high-grade CIN harbored in ASC-US and LSIL Pap cytology cases

17 June 2010
PROFIBRIX and CSL Behring Enter into Fibrinogen and Thrombin Supply Agreement

15 June 2010
Pieris Initiates Phase I Clinical Trial for Lead Anticalin Compound

7 June 2010
Pieris AG Appoints Chief Scientific Officer

27 May 2010
mtm’s CINtec® PLUS, delivers new solution to manage Pap negative but HPV positive women

24 May 2010
ABLYNX - NANOBODY® Lead Candidate Selected by Boehringer Ingelheim for Development in Alzheimer’s Disease

17 May 2010
Gilde Healthcare II sells its stake in FlowCardia

30 April 2010
PIERIS Announces Positive Preclinical Data on c-Met Anticalin Drug Program

26 April 2010
SANTARIS PHARMA advances RNA-targeted drug development candidate against PCSK9, an important new target for the treatment of high cholesterol

26 April 2010
Inverness Medical and BG MEDICINE to Develop Galectin-3 Test for Inverness’ Triage® Meter

26 April 2010
SYMPHOGEN - Sympress II Production System Enables Single-Batch Recombinant Polyclonal Antibody Manufacturing

20 April 2010
AGENDIA and Ferrer inCode Expand MammaPrint(r) Distribution Agreement to Latin America

1 April 2010
SYMPHOGEN Announces Initiation of Phase 1/2 Trial of Sym004 in Patients with Advanced Solid Tumors in the US

26 March 2010
ABLYNX Selects a Novel Pre-Clinical Development Candidate for Administration via Pulmonary Delivery

17 March 2010
AGENDIA to Play Pivotal Role in ISPY-2 Trial for Breast Cancer, 12 Cancer Drugs Tested, 20 Leading U.S. Cancer Centers Involved

15 March 2010
Ablynx successfully raises €50 million with Secondary Public Offering

11 March 2010
ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer

10 March 2010
AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

8 March 2010
mtm laboratories Announces the European Launch of CINtec(R) PLUS

8 March 2010
BG Medicine and Abbott to Develop Galectin-3 Test for the i-STAT® System

19 February 2010
ABLYNX Receives EUR 1.2 Million Grant to Further Advance its Anti-IL-6R Programme, ALX-0061

16 February 2010
MTM LABORATORIES - CINtec® p16 Histology test increases accuracy in diagnosing high grade cervical lesions

11 February 2010
ABLYNX Win Patent Opposition Case

11 February 2010
ABLYNX Selects GPCR Targeting Development Candidate and Announces New Data on Alternative Routes of Delivery

9 February 2010
FlowCardia, Inc. Initiates CENTRAL Study Enrollment

29 January 2010
BG MEDICINE files Registration Statement for proposed Initial Public Offering at NASDAQ

28 January 2010
BG Medicine Announces Receipt Of CE Mark For Its Galectin-3 Blood Test

28 January 2010
Conatus Pharmaceuticals initiates combination trial of CTS-1027 with pegylated interferon and ribavirin for HCV

27 January 2010
BG Medicine Announces Receipt of CE Mark for its Galectin-3 Blood Test and Initiates Commercialization in the European Union

11 January 2010
Symphogen Publishes Pre-Clinical Data in Cancer Research Demonstrating Superior Efficacy of Anti-EGFR Sym004

11 January 2010
AMT submits its lead product Glybera® Application for Marketing Authorisation Application to EMA

6 January 2010
Amsterdam Molecular Therapeutics receives € 4 million Innovation Credit for Duchenne Muscular Dystrophy programme

4 January 2010
Pieris Appoints a New CEO

Bottles with golden caps